{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:01:33Z","timestamp":1770062493638,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejphar.2024.177221","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T17:57:21Z","timestamp":1734717441000},"page":"177221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Experimental study on the inhibitory effect of Halofuginone on NSCLC"],"prefix":"10.1016","volume":"988","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4010-5520","authenticated-orcid":false,"given":"Yuehua","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peipei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixuan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangtian","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.177221_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109871","article-title":"Lung cancer cells and their sensitivity\/resistance to cisplatin chemotherapy: role of microRNAs and upstream mediators","volume":"78","author":"Ashrafizadeh","year":"2021","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2024.177221_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.ejphar.2024.177221_bib4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/jhep.2001.21408","article-title":"Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats","volume":"33","author":"Bruck","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2024.177221_bib5","doi-asserted-by":"crossref","first-page":"50302","DOI":"10.18632\/oncotarget.10367","article-title":"Halofuginone and artemisinin synergistically arrest cancer cells at the G1\/G0 phase by upregulating p21Cip1 and p27Kip1","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2024.177221_bib6","doi-asserted-by":"crossref","first-page":"24148","DOI":"10.18632\/oncotarget.4376","article-title":"Halofuginone inhibits colorectal cancer growth through suppression of Akt\/mTORC1 signaling and glucose metabolism","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2024.177221_bib7","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/cdd.2009.49","article-title":"Superoxide is the major reactive oxygen species regulating autophagy","volume":"16","author":"Chen","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2024.177221_bib8","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.4161\/cc.10.14.16494","article-title":"From Plk1 to Plk5: functional evolution of polo-like kinases","volume":"10","author":"de C\u00e1rcer","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejphar.2024.177221_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026713","article-title":"Halofuginone has anti-proliferative effects in acute promyelocytic leukemia by modulating the transforming growth factor beta signaling pathway","volume":"6","author":"de Figueiredo-Pontes","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2024.177221_bib10","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/jcsm.12967","article-title":"The association between skeletal muscle measures and chemotherapy-induced toxicity in non-small cell lung cancer patients","volume":"13","author":"de Jong","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ejphar.2024.177221_bib11","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.ejca.2005.12.027","article-title":"Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours","volume":"42","author":"de Jonge","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejphar.2024.177221_bib12","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/cbin.11399","article-title":"Anticarcinogenic effects of halofuginone on lung-derived cancer cells","volume":"44","author":"Demiroglu-Zergeroglu","year":"2020","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.ejphar.2024.177221_bib13","first-page":"1982","article-title":"Inhibition of matrix metalloproteinase-2 expression and bladder carcinoma metastasis by halofuginone","volume":"5","author":"Elkin","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2024.177221_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbamcr.2014.09.023","article-title":"Autophagy in acute leukemias: a double-edged sword with important therapeutic implications","volume":"1853","author":"Evangelisti","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2024.177221_bib15","article-title":"Oncogenic signaling pathways in the cancer genome atlas","author":"Francisco","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2024.177221_bib16","article-title":"Apoptosis, necroptosis, and pyroptosis as alternative cell death pathways induced by chemotherapeutic agents?","volume":"1878","author":"Gieleci\u0144ska","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.ejphar.2024.177221_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.7150\/ijms.66737","article-title":"Cell death mechanisms induced by synergistic effects of halofuginone and artemisinin in colorectal cancer cells","volume":"19","author":"Gong","year":"2022","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.ejphar.2024.177221_bib18","first-page":"275","article-title":"Are we missing the target? Cancer stem cells and drug resistance in non-small cell lung cancer","volume":"9","author":"Gottschling","year":"2012","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.ejphar.2024.177221_bib19","first-page":"15863","article-title":"Effect of halofuginone on the inhibition of proliferation and invasion of hepatocellular carcinoma HepG2 cell line","volume":"8","author":"Huo","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.ejphar.2024.177221_bib21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/QAI.0b013e3181fc0141","article-title":"Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma","volume":"56","author":"Koon","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.ejphar.2024.177221_bib22","doi-asserted-by":"crossref","first-page":"14413","DOI":"10.18632\/oncotarget.3891","article-title":"Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases","volume":"6","author":"Lamora","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2024.177221_bib23","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10571-015-0166-x","article-title":"ROS and autophagy: interactions and molecular regulatory mechanisms","volume":"35","author":"Li","year":"2015","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2024.177221_bib24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/08977194.2022.2113394","article-title":"Halofuginone inhibits cell proliferation and AKT\/mTORC1 signaling in uterine leiomyoma cells","volume":"40","author":"Lin","year":"2022","journal-title":"Growth Factors"},{"key":"10.1016\/j.ejphar.2024.177221_bib25","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.2147\/OTT.S92518","article-title":"Inhibition of TGF-\u03b2 signaling with halofuginone can enhance the antitumor effect of irradiation in Lewis lung cancer","volume":"8","author":"Lin","year":"2015","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ejphar.2024.177221_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22942","article-title":"Imbalanced GSH\/ROS and sequential cell death","volume":"36","author":"Liu","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.ejphar.2024.177221_bib27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1046\/j.0022-202x.2001.01690.x","article-title":"Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-beta-mediated Smad 3 activation in fibroblasts","volume":"118","author":"McGaha","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejphar.2024.177221_bib28","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1021\/jm0704090","article-title":"Natural products as leads to potential drugs: an old process or the new hope for drug discovery?","volume":"51","author":"Newman","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2024.177221_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/15548627.2018.1511504","article-title":"TFEB-driven endocytosis coordinates MTORC1 signaling and autophagy","volume":"15","author":"Nnah","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.ejphar.2024.177221_bib30","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.tcb.2022.09.009","article-title":"Plasticity of cancer invasion and energy metabolism","volume":"33","author":"Parlani","year":"2023","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejphar.2024.177221_bib31","article-title":"The unfolded protein response governs integrity of the haematopoietic stem-cell pool during stress","author":"Peter van","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2024.177221_bib32","doi-asserted-by":"crossref","first-page":"14778","DOI":"10.3748\/wjg.v20.i40.14778","article-title":"Halofuginone for fibrosis, regeneration and cancer in the gastrointestinal tract","volume":"20","author":"Pines","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2024.177221_bib33","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3390\/molecules20010573","article-title":"Halofuginone - the multifaceted molecule","volume":"20","author":"Pines","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2024.177221_bib34","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.molmed.2019.04.012","article-title":"Abandoning the notion of non-small cell lung cancer","volume":"25","author":"Relli","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejphar.2024.177221_bib35","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.freeradbiomed.2013.11.010","article-title":"p38(MAPK)-regulated induction of p62 and NBR1 after photodynamic therapy promotes autophagic clearance of ubiquitin aggregates and reduces reactive oxygen species levels by supporting Nrf2-antioxidant signaling","volume":"67","author":"Rubio","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2024.177221_bib36","article-title":"Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins","author":"Rumani","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2024.177221_bib37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/157340609788185846","article-title":"Synthesis and comparison of antimalarial activity of febrifugine derivatives including halofuginone","volume":"5","author":"Samant","year":"2009","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejphar.2024.177221_bib38","article-title":"The domiNO effect turns macrophage activation deadly","author":"Shelly","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2024.177221_bib39","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1126\/science.1172638","article-title":"Halofuginone inhibits TH17 cell differentiation by activating the amino acid starvation response","volume":"324","author":"Sundrud","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2024.177221_bib40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jcis.2021.11.190","article-title":"Disrupting stromal barriers to enhance photothermal-chemo therapy using a halofuginone-loaded Janus mesoporous nanoplatform","volume":"610","author":"Tang","year":"2022","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejphar.2024.177221_bib41","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1111\/1750-3841.15900","article-title":"Docosahexaenoic acid monoglyceride induces apoptosis and autophagy in breast cancer cells via lipid peroxidation-mediated endoplasmic reticulum stress","volume":"86","author":"Wang","year":"2021","journal-title":"J. Food Sci."},{"key":"10.1016\/j.ejphar.2024.177221_bib42","doi-asserted-by":"crossref","first-page":"18970","DOI":"10.1002\/jcp.28537","article-title":"miR-31 shuttled by halofuginone-induced exosomes suppresses MFC-7 cell proliferation by modulating the HDAC2\/cell cycle signaling axis","volume":"234","author":"Xia","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2024.177221_bib43","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1158\/1055-9965.EPI-07-0111","article-title":"Deficient G2-M and S checkpoints are associated with increased lung cancer risk: a case-control analysis","volume":"16","author":"Xing","year":"2007","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.ejphar.2024.177221_bib44","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.biopha.2017.12.106","article-title":"FPHPB inhibits gastric tumor cell proliferation by inducing G2-M cell cycle arrest","volume":"98","author":"Xue","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2024.177221_bib45","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/med.21963","article-title":"Advances of antitumor drug discovery in traditional Chinese medicine and natural active products by using multi-active components combination","volume":"43","author":"Zhao","year":"2023","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejphar.2024.177221_bib46","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.2147\/IJN.S289096","article-title":"Encapsulating halofuginone hydrobromide in TPGS polymeric micelles enhances efficacy against triple-negative breast cancer cells","volume":"16","author":"Zuo","year":"2021","journal-title":"Int. J. Nanomed."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924009117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924009117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T10:15:41Z","timestamp":1742033741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924009117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":44,"alternative-id":["S0014299924009117"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177221","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experimental study on the inhibitory effect of Halofuginone on NSCLC","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177221","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"177221"}}